<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is increasing worldwide in epidemic proportions </plain></SENT>
<SENT sid="1" pm="."><plain>Its associated morbidity and mortality is imposing a major burden on the health care system </plain></SENT>
<SENT sid="2" pm="."><plain>Based on a better understanding of the pathophysiology of <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo>, clinical trials on the prevention of <z:mp ids='MP_0002055'>diabetes</z:mp> have been performed </plain></SENT>
<SENT sid="3" pm="."><plain>It has now been demonstrated that diet and exercise, <z:chebi fb="0" ids="6801">metformin</z:chebi>, <z:chebi fb="0" ids="2376">acarbose</z:chebi>, and <z:chebi fb="0" ids="9753">troglitazone</z:chebi> can prevent or at least delay the development of <z:mp ids='MP_0002055'>diabetes</z:mp> in subjects with <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) </plain></SENT>
<SENT sid="4" pm="."><plain>It is now generally accepted that <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> are major factors involved in the development of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>The relative contribution of <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> versus <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> on the pathogenesis of <z:mp ids='MP_0002055'>diabetes</z:mp> has aroused much debate </plain></SENT>
<SENT sid="6" pm="."><plain>These two processes should be studied in relation to one another: their relationship is best described as hyperbolic in nature </plain></SENT>
<SENT sid="7" pm="."><plain>When this relationship is taken into consideration, it becomes evident that subjects at risk of developing type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> have <z:hpo ids='HP_0006279'>beta-cell dysfunction</z:hpo> before they develop <z:hpo ids='HP_0000833'>glucose intolerance</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> may be mostly explained by the presence of <z:hpo ids='HP_0001513'>obesity</z:hpo> and accelerate the progression to <z:mp ids='MP_0002055'>diabetes</z:mp> in subjects with the propensity to beta-cell failure </plain></SENT>
<SENT sid="9" pm="."><plain>By the time <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> occurs, impairment in both insulin sensitivity and insulin secretion are present </plain></SENT>
<SENT sid="10" pm="."><plain>There are still few data on insulin sensitivity and insulin secretion from the trials on the prevention of <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>The few data that we do have suggest that most interventions mostly have an effect on <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>By reducing <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, they protect and preserve the beta-cell function </plain></SENT>
<SENT sid="13" pm="."><plain>No intervention has yet shown any direct effect on beta-cell function </plain></SENT>
</text></document>